Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Door-Through-Door rides: a new way to help Alzheimer's patients keep appointments?

NCT ID NCT06850870

Symptom relief Sponsor: Onward Health, Inc Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jul 22, 2026 · Updated 4 times

Summary

This study tests a rideshare service where drivers are specially trained to assist older adults, including those with Alzheimer's or memory problems. The drivers help riders from door to door, even handing them off to clinic staff. The goal is to see if this service reduces missed medical appointments compared to standard curb-to-curb rideshare. About 120 people aged 60 and older in the San Francisco Bay Area will take part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Door-through-door companion rideshare service with trained drivers
What this could lead to
If successful, this service could help older adults with memory problems get to more medical appointments, potentially improving their health and quality of life.
What could go wrong
This is a small early-phase pilot study, so results may not apply to everyone. The service may not reduce missed appointments or improve well-being as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All participants (or their surrogate) have the capacity to agree to allow Onward service for transportation; * have scheduled medical appointments at partner practices of Onward; * ages 60+ * community-dwelling; * 60 participants who self-reported cognitive problems, such as memory issue, or have mild cognitive impairment, subjective cognitive decline, or AD/ADRD diagnosis * Resides and attends appointments in the following San Francisco Bay Area Counties (San Francisco, Alameda, Contra Costa, Marin, San Mateo, Sonoma) Exclusion Criteria: * current enrollment in another transportation study; * already using any type of free or heavily subsized transportation service; * enrollees with comfort care only; * Not wheelchair bound, e.g. if using a wheelchair must be foldable and must be able to transfer * Transient, lacking consistent long term housing * Resides outside of the San Francisco Bay Area

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alzheimer disease or associated disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction dementia subjective cognitive decline

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alzheimer disease or associated disorder Cognitive decline Dementia

Contacts and locations

Locations

  • Onward Health HQ

    San Leandro, California, 94577, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.